Aydin, V. Et Al. 2019. Relative risk of tuberculosis in patients with rheumatic diseases managed with anti-tumour necrosis factor-alpha therapy: A nationwide cohort study. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.44, no.4 , 553-560.

Aydin, V., AKICI, A., Isli, F., Aksoy, M., Aydin, M., & Gursoz, H., (2019). Relative risk of tuberculosis in patients with rheumatic diseases managed with anti-tumour necrosis factor-alpha therapy: A nationwide cohort study. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.44, no.4, 553-560.

Aydin, Volkan Et Al. "Relative risk of tuberculosis in patients with rheumatic diseases managed with anti-tumour necrosis factor-alpha therapy: A nationwide cohort study," JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.44, no.4, 553-560, 2019

Aydin, Volkan Et Al. "Relative risk of tuberculosis in patients with rheumatic diseases managed with anti-tumour necrosis factor-alpha therapy: A nationwide cohort study." JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.44, no.4, pp.553-560, 2019

Aydin, V. Et Al. (2019) . "Relative risk of tuberculosis in patients with rheumatic diseases managed with anti-tumour necrosis factor-alpha therapy: A nationwide cohort study." JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.44, no.4, pp.553-560.

@article{article, author={Volkan Aydin Et Al. }, title={Relative risk of tuberculosis in patients with rheumatic diseases managed with anti-tumour necrosis factor-alpha therapy: A nationwide cohort study}, journal={JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS}, year=2019, pages={553-560} }